Referências
Principais artigos
American College of Radiology. ACR appropriateness criteria: second and third trimester bleeding. 2020 [internet publication].Texto completo
Society for Maternal-Fetal Medicine (SMFM), Gyamfi-Bannerman C. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period. Am J Obstet Gynecol. 2018 Jan;218(1):B2-8.Texto completo Resumo
Artigos de referência
1. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006 Oct;108(4):1005-16. Resumo
2. Ananth CV, Lavery JA, Vintzileos AM, et al. Severe placental abruption: clinical definition and associations with maternal complications. Am J Obstet Gynecol. 2016 Feb;214(2):272.e1-272.Texto completo Resumo
3. Ananth CV, Keyes KM, Hamilton A, et al. An international contrast of rates of placental abruption: an age-period-cohort analysis. PLoS One. 2015 May 27;10(5):e0125246. Resumo
4. Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011 Feb;90(2):140-9. Resumo
5. Ventolini G, Samlowski R, Hood DL. Placental findings in low-risk, singleton, term pregnancies after uncomplicated deliveries. Am J Perinatol. 2004 Aug;21(6):325-8. Resumo
6. Ananth CV, Oyelese Y, Yeo L, et al. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol. 2005 Jan;192(1):191-8. Resumo
7. Ananth CV, Oyelese Y, Prasad V, et al. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):15-21. Resumo
8. Kurdi W, Campbell S, Aquilina J, et al. The role of color Doppler imaging of the uterine arteries at 20 weeks' gestation in stratifying antenatal care. Ultrasound Obstet Gynecol. 1998 Nov;12(5):339-45. Resumo
9. Harrington K, Cooper D, Lees C, et al. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol. 1996 Mar;7(3):182-8. Resumo
10. Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol. 1992 Aug;99(8):651-4. Resumo
11. Ananth CV, Peltier MR, Chavez MR, et al. Recurrence of ischemic placental disease. Obstet Gynecol. 2007 Jul;110(1):128-33. Resumo
12. Brenner B. Clinical management of thrombophilia-related placental vascular complications. Blood. 2004 Jun 1;103(11):4003-9. Resumo
13. ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy. Obstet Gynecol. 2018 Jul;132(1):e18-e34. Resumo
14. Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol. 1999 Apr;93(4):622-8. Resumo
15. Zetterstrom K, Lindeberg SN, Haglund B, et al. Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gynecol Scand. 2005 May;84(5):419-24. Resumo
16. Williams MA, Mittendorf R, Monson RR. Chronic hypertension, cigarette smoking, and abruptio placentae. Epidemiology. 1991 Nov;2(6):450-3. Resumo
17. Abu-Heija A, al-Chalabi H, el-Iloubani N. Abruptio placentae: risk factors and perinatal outcome. J Obstet Gynaecol Res. 1998 Apr;24(2):141-4. Resumo
18. Tikkanen M, Nuutila M, Hiilesmaa V, et al. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85(6):700-5. Resumo
19. Bhattacharya S, Campbell DM. The incidence of severe complications of preeclampsia. Hypertens Pregnancy. 2005;24(2):181-90. Resumo
20. Shobeiri F, Masoumi SZ, Jenabi E. The association between maternal smoking and placenta abruption: a meta-analysis. J Matern Fetal Neonatal Med. 2017 Aug;30(16):1963-7. Resumo
21. Raymond EG, Mills JL. Placental abruption. Maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand. 1993 Nov;72(8):633-9. Resumo
22. Landy HJ, Hinson J. Placental abruption associated with cocaine use: case report. Reprod Toxicol. 1987-1988;1(3):203-5. Resumo
23. Addis A, Moretti ME, Ahmed Syed F, et al. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 2001 Jul-Aug;15(4):341-69. Resumo
24. Handler A, Kistin N, Davis F, et al. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol. 1991 Apr 15;133(8):818-25. Resumo
25. Lane PL. Traumatic fetal deaths. J Emerg Med. 1989 Sep-Oct;7(5):433-35. Resumo
26. Schiff MA, Holt VL. Pregnancy outcomes following hospitalization for motor vehicle crashes in Washington State from 1989 to 2001. Am J Epidemiol. 2005 Mar 15;161(6):503-10.Texto completo Resumo
27. El-Kady D, Gilbert WM, Anderson J, et al. Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population. Am J Obstet Gynecol. 2004 Jun;190(6):1661-8. Resumo
28. Tikkanen M, Nuutila M, Hiilesmaa V, et al. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand. 2006;85(1):40-4. Resumo
29. Getahun D, Oyelese Y, Salihu HM, et al. Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol. 2006 Apr;107(4):771-8. Resumo
30. Lydon-Rochelle M, Holt VL, Easterling TR, et al. First-birth cesarean and placental abruption or previa at second birth(1). Obstet Gynecol. 2001 May;97(5 Pt 1):765-9. Resumo
31. Yang Q, Wen SW, Oppenheimer L, et al. Association of caesarean delivery for first birth with placenta praevia and placental abruption in second pregnancy. BJOG. 2007 May;114(5):609-13. Resumo
32. Ananth CV, Oyelese Y, Srinivas N, et al. Preterm premature rupture of membranes, intrauterine infection, and oligohydramnios: risk factors for placental abruption. Obstet Gynecol. 2004 Jul;104(1):71-7. Resumo
33. Kramer MS, Usher RH, Pollack R, et al. Etiologic determinants of abruptio placentae. Obstet Gynecol. 1997 Feb;89(2):221-6. Resumo
34. Hung TH, Hsieh CC, Hsu JJ, et al. Risk factors for placental abruption in an Asian population. Reprod Sci. 2007 Jan;14(1):59-65. Resumo
35. Rasmussen S, Irgens LM, Dalaker K. Outcome of pregnancies subsequent to placental abruption: a risk assessment. Acta Obstet Gynecol Scand. 2000 Jun;79(6):496-501. Resumo
36. Rasmussen S, Irgens LM, Albrechtsen S, et al. Women with a history of placental abruption: when in a subsequent pregnancy should special surveillance for a recurrent placental abruption be initiated? Acta Obstet Gynecol Scand. 2001 Aug;80(8):708-12. Resumo
37. Toivonen S, Heinonen S, Anttila M, et al. Obstetric prognosis after placental abruption. Fetal Diagn Ther. 2004 Jul-Aug;19(4):336-41. Resumo
38. Ruiter L, Ravelli AC, de Graaf IM, et al. Incidence and recurrence rate of placental abruption: a longitudinal linked national cohort study in the Netherlands. Am J Obstet Gynecol. 2015 Oct;213(4):573.e1-8. Resumo
39. Salihu HM, Bekan B, Aliyu MH, et al. Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol. 2005 Jul;193(1):198-203. Resumo
40. Sheiner E, Bashiri A, Levy A, et al. Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas. J Reprod Med. 2004 Mar;49(3):182-6. Resumo
41. Prochazka M, Lubusky M, Slavik L, et al. Frequency of selected thrombophilias in women with placental abruption. Aust N Z J Obstet Gynaecol. 2007 Aug;47(4):297-301. Resumo
42. Facchinetti F. Factor V Leiden in pregnancies complicated by placental abruption. BJOG. 2004 Jan;111(1):93. Resumo
43. Kinzler WL, Prasad V, Ananth CV, et al. The effect of maternal thrombophilia on placental abruption: Histologic correlates. J Matern Fetal Neonatal Med. 2009 Mar;22(3):243-8. Resumo
44. Jaaskelainen E, Keski-Nisula L, Toivonen S, et al. MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy. 2006;25(2):73-80. Resumo
45. Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005 Sep;106(3):517-24. Resumo
46. American College of Radiology. ACR appropriateness criteria: second and third trimester bleeding. 2020 [internet publication].Texto completo
47. Notelovitz M, Bottoms SF, Dase DF, et al. Painless abruptio placentae. Obstet Gynecol. 1979 Feb;53(2):270-2. Resumo
48. Ananth CV, Berkowitz GS, Savitz DA, et al. Placental abruption and adverse perinatal outcomes. JAMA. 1999 Nov 3;282(17):1646-51.Texto completo Resumo
49. Usui R, Matsubara S, Ohkuchi A, et al. Fetal heart rate pattern reflecting the severity of placental abruption. Arch Gynecol Obstet. 2008 Mar;277(3):249-53. Resumo
50. Visser GHA, Thommesen T, Di Renzo GC, et al. FIGO/ICM guidelines for preventing Rhesus disease: a call to action. Int J Gynaecol Obstet. 2021 Feb;152(2):144-7.Texto completo Resumo
51. Atkinson A, Santolaya-Forgas J, Matta P, et al. The sensitivity of the Kleihauer-Betke test for placental abruption. J Obstet Gynaecol. 2015 Feb;35(2):139-41. Resumo
52. Emery CL, Morway LF, Chung-Park M, et al. The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Arch Pathol Lab Med. 1995 Nov;119(11):1032-7. Resumo
53. Committee on practice bulletins—obstetrics and the American Institute of Ultrasound in Medicine. Practice bulletin No. 175: ultrasound in pregnancy. Obstet Gynecol. 2016 Dec;128(6):e241-56. Resumo
54. Kikutani M, Ishihara K, Araki T. Value of ultrasonography in the diagnosis of placental abruption. J Nippon Med Sch. 2003 Jun;70(3):227-33.Texto completo Resumo
55. Yeo L, Ananth C, Vintzileos A. Placental abruption. In: Sciarra J, ed. Gynecology and obstetrics. Hagerstown, MD: Lippincott, Williams & Wilkins; 2004.
56. Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. 2002 Aug;21(8):837-40. Resumo
57. Shinde GR, Vaswani BP, Patange RP, et al. Diagnostic performance of ultrasonography for detection of abruption and its clinical correlation and maternal and foetal outcome. J Clin Diagn Res. 2016 Aug;10(8):QC04-7.Texto completo Resumo
58. Dhanraj D, Lambers D. The incidences of positive Kleihauer-Betke test in low-risk pregnancies and maternal trauma patients. Am J Obstet Gynecol. 2004 May;190(5):1461-3. Resumo
59. Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018 Jan 13;391(10116):125-32.Texto completo Resumo
60. Society of Obstetricians and Gynaecologists of Canada. Guidelines for the Management of a Pregnant Trauma Patient. Jun 2015 [internet publication].Texto completo
61. Society for Maternal-Fetal Medicine (SMFM), Gyamfi-Bannerman C. Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: Management of bleeding in the late preterm period. Am J Obstet Gynecol. 2018 Jan;218(1):B2-8.Texto completo Resumo
62. Kayani SI, Walkinshaw SA, Preston C. Pregnancy outcome in severe placental abruption. BJOG. 2003 Jul;110(7):679-83. Resumo
63. American College of Obstetricians and Gynecologists. Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation. Aug 2017 [internet publication].Texto completo
64. American College of Obstetricians and Gynecologists. Committee opinion no. 455: magnesium sulfate before anticipated preterm birth for neuroprotection. Mar 2010 [internet publication].Texto completo
65. Crowther CA, Brown J, McKinlay CJ, et al. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2014 Aug 15;2014(8):CD001060. Resumo
66. Saller DN Jr, Nagey DA, Pupkin MJ, et al. Tocolysis in the management of third trimester bleeding. J Perinatol. 1990 Jun;10(2):125-8. Resumo
67. Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol. 1990 Jun;10(2):125-8. Resumo
68. Henderson CE, Goldman B, Divon MY. Ritodrine therapy in the presence of chronic abruptio placentae. Obstet Gynecol. 1992 Sep;80(3 Pt 2):510-2. Resumo
69. US Food and Drug Administration. FDA drug safety communication: FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. May 2013 [internet publication].Texto completo
70. Medicines and Healthcare products Regulatory Agency. Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy. 2019 May;12(10):3.Texto completo
71. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol. 2001 Feb 15;153(4):332-7.Texto completo Resumo
72. Ananth CV, Vintzileos AM. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol. 2008 Mar;35(1):53-67. Resumo
73. Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006 Dec;195(6):1557-63. Resumo
74. Gibbs JM, Weindling AM. Neonatal intracranial lesions following placental abruption. Eur J Pediatr. 1994 Mar;153(3):195-7. Resumo
75. Pitaphrom A, Sukcharoen N. Pregnancy outcomes in placental abruption. J Med Assoc Thai. 2006 Oct;89(10):1572-8. Resumo
76. Rasmussen S, Irgens LM, Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. Br J Obstet Gynaecol. 1997 Nov;104(11):1292-5. Resumo
77. Furuhashi M, Kurauchi O, Suganuma N. Pregnancy following placental abruption. Arch Gynecol Obstet. 2002 Nov;267(1):11-3. Resumo
78. Ananth CV, Patrick HS, Ananth S, et al. Maternal cardiovascular and cerebrovascular health after placental abruption: a systematic review and meta-analysis (CHAP-SR). Am J Epidemiol. 2021 Dec 1;190(12):2718-29.Texto completo Resumo
79. Lockwood CJ, Toti P, Arcuri F, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol. 2005 Nov;167(5):1443-9. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal